The MCF10 xenograft model consists of a number of variants derived from a single patient which include normal immortalized breast epithelial cells, estrogen responsive premalignant variants, a variant which forms rapidly growing but preinvasive ductal carcinoma in situ, and estrogen independent malignant variants in immune deficient mice. This panel of human breast cell lines, on a common genetic background, representing multiple events in breast disease will be used for comparative studies to identify genetic alterations which occur with progression. We hypothesize that E2 independent malignant lines may constitutively express proteins which are altered by E2 in the premalignant stages (E2 accelerates progression of MCF10AT1 xenografts). Thus, first priority will be to identify proteins expressed constitutively in malignant variants which are also induced by E2 in premalignant MCF10AT1 cells. It is proposed to look at relative levels of proteins rather than nucleic acids. The methods to be used to monitor protein expression involve the use of nonporous reversed phase HPLC separations which can rapidly separate large numbers of proteins from whole cell lysates and provide efficient recovery of those proteins in the liquid phase for further analysis. The method will be combined with a first dimension separation using liquid phase isoelectric focusing (IEF) to prefractionate proteins according to pI. The result is a 2-D protein map analagous to 2-D gel electrophoresis where the expression of hundreds of proteins can be imaged and monitored. Matrix-assisted Laser Desorption/Ionization time-of- flight mass spectrometry will mass size each target protein and digestion by trypsin or Glu-C will generate a peptide map. The molecular weight and peptide maps can be used to identify each protein and electrospray ionization mass spectometry will be used to pinpoint modifications such as missense mutations and post- translational events such as phosphorylation. The MCF10 system provides a direct means to test the cause and effect relationship of the detected change to the malignant phenotype. We will use the novel technique of gene conversion to inhibit gene expression or introduce missense mutations in cells at defined stages of progression and to monitor the effect of these alterations on progression as determined by stage of disease formed in xenografts.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA090503-04
Application #
6849197
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Sussman, Daniel J
Project Start
2002-02-20
Project End
2007-01-31
Budget Start
2005-02-01
Budget End
2007-01-31
Support Year
4
Fiscal Year
2005
Total Cost
$230,468
Indirect Cost
Name
Wayne State University
Department
Pathology
Type
Schools of Medicine
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Bardag-Gorce, Fawzia; Hoft, Richard; Meepe, Imara et al. (2017) Proteasomes in corneal epithelial cells and cultured autologous oral mucosal epithelial cell sheet (CAOMECS) graft used for the ocular surface regeneration. Ocul Surf 15:749-758
Zhang, Hong-Liang; Liu, Zhi-Hong; Luo, Qin et al. (2017) Paradoxical embolism: Experiences from a single center. Chronic Dis Transl Med 3:123-128
Patwa, Tasneem H; Wang, Yanfei; Miller, Fred R et al. (2008) A novel phosphoprotein analysis scheme for assessing changes in premalignant and malignant breast cell lines using 2D liquid separations, protein microarrays and tandem mass spectrometry. Proteomics Clin Appl 3:51-66
Wang, Yanfei; Ao, Xiaoping; Vuong, Huy et al. (2008) Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach. J Proteome Res 7:4313-25
Buchanan, Nathan S; Zhao, Jia; Zhu, Kan et al. (2007) Differential expression of acidic proteins with progression in the MCF10 model of human breast disease. Int J Oncol 31:941-9
Zhao, Jia; Chang, Andrew C; Li, Chen et al. (2007) Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping. Mol Cell Proteomics 6:987-99
Zhu, Yi; Wu, Rong; Sangha, Navneet et al. (2006) Classifications of ovarian cancer tissues by proteomic patterns. Proteomics 6:5846-56
Zhao, Jia; Zhu, Kan; Lubman, David M et al. (2006) Proteomic analysis of estrogen response of premalignant human breast cells using a 2-D liquid separation/mass mapping technique. Proteomics 6:3847-61
Yoo, Chul; Pal, Manoj; Miller, Fred R et al. (2006) Toward high sequence coverage of proteins in human breast cancer cells using on-line monolith-based HPLC-ESI-TOF MS compared to CE MS. Electrophoresis 27:2126-38
Zheng, Suping; Yoo, Chul; Delmotte, Nathanael et al. (2006) Monolithic column HPLC separation of intact proteins analyzed by LC-MALDI using on-plate digestion: An approach to integrate protein separation and identification. Anal Chem 78:5198-204

Showing the most recent 10 out of 19 publications